SGLT2 Inhibitors in Diabetic Kidney Disease and HF
Speaker: Sami Mazbar, MD
Target Audience
All Physicians
Learning Objectives
- Evaluate the safety and efficacy data of the SGLT2 inhibitors in patients with diabetes mellitus and cardiovascular disease
- Discuss the reno-protective effects of SGLT2 inhibitors
- Incorporate available SGLT2 inhibitors into appropriate and effective treatment plan in adults with type 2 DM and cardiovascular disease based on current recommendations
Additional Information
The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations. The CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products.
The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations (Commercial Interest). The CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products.
Kaiser Santa Clara is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Kaiser Santa Clara designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Medical Knowledge (MK) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance